<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04534140</url>
  </required_header>
  <id_info>
    <org_study_id>19-002095</org_study_id>
    <nct_id>NCT04534140</nct_id>
  </id_info>
  <brief_title>Skin Hydration in Persons With Acne After Dietary Supplementation With Botanical Antioxidants</brief_title>
  <acronym>KIWIBOOSTER</acronym>
  <official_title>Evaluating the Effect of an Antioxidant Nutraceutical on Skin Health, as Measured by Investigator Global Assessment, Quality-of-Life, and Corneometry, in Persons With Mild to Moderately Severe Facial Acne Vulgaris</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Los Angeles</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, Los Angeles</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Antioxidants have been studied for their abilities to combat reactive oxygen species in a&#xD;
      multitude of conditions. This study aims to assess whether the botanical dietary supplement&#xD;
      'Halo Beauty Kiwi Booster' (HBKB), taken orally daily for 8 weeks, can assist with Acne&#xD;
      vulgaris as well as skin hydration and quality of life for those with acne.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will be a 2-armed investigational trial with one group receiving botanical dietary&#xD;
      supplement and one placebo group provided with the similar supplement vehicle. The trial will&#xD;
      be double-blind, randomized, parallel-group study. The investigational group will receive the&#xD;
      botanical dietary supplement 'Halo Beauty Kiwi Booster' (HBKB), to be taken orally daily for&#xD;
      8 weeks. Control group participants will receive the HBKB botanical dietary supplement&#xD;
      vehicle as a placebo to be taken orally daily for 8 weeks.Participants will have their skin&#xD;
      assessed&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Contract not negotiated.&#xD;
  </why_stopped>
  <start_date type="Anticipated">January 25, 2021</start_date>
  <completion_date type="Anticipated">January 24, 2023</completion_date>
  <primary_completion_date type="Anticipated">January 24, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>This will be a 2-armed investigational group (botanical dietary supplement) and placebo group (supplement vehicle), double-blind, randomized, parallel-group study.</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Botanical Impact on hydration in those with Acne Vulgaris</measure>
    <time_frame>8 weeks</time_frame>
    <description>To prospectively appraise changes in stratum corneum hydration levels in persons with Acne Vulgaris (AV) after dietary supplementation with a compilation of botanical antioxidants.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Botanical Impact on Acne Vulgaris</measure>
    <time_frame>8 weeks</time_frame>
    <description>To prospectively appraise changes in Investigator Global Assessment (IGA) of Facial AV after dietary supplementation with a compilation of botanical antioxidants.Scale is 0-4 (0 - clear and 4 - severe)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Botanical Impact on Quality of Life in those with Acne</measure>
    <time_frame>8 weeks</time_frame>
    <description>To prospectively appraise changes in AV related quality-of-life (AVQoL) after dietary supplementation with a compilation of botanical antioxidants.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Acne Vulgaris</condition>
  <condition>Acne</condition>
  <arm_group>
    <arm_group_label>HBKB Capsule</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Experimental group participants will take one capsule of the HBKB botanical dietary supplement orally, once daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HBKB Capsule Vehicle</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Control group participants will take one capsule of the HBKB botanical dietary supplement vehicle orally, once daily</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>HBKB Capsule</intervention_name>
    <description>The botanical dietary supplement 'Halo Beauty Kiwi Booster' (HBKB) taken daily orally.</description>
    <arm_group_label>HBKB Capsule</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>HBKB Supplement Vehicle</intervention_name>
    <description>Control group participants will take one capsule of the HBKB botanical dietary supplement vehicle orally, once daily</description>
    <arm_group_label>HBKB Capsule Vehicle</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adults 18-35 years of age able to provide consent to participate&#xD;
&#xD;
          -  IGA of mild to moderately severe facial Acne Vulgaris (AV) at screening&#xD;
&#xD;
          -  Potential participants with mild to moderately severe facial AV and with AV on their&#xD;
             neck, shoulders, chest and/or back body surface areas may be included.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  An Investigator Global Assessment IGA of severe facial, neck, back or truncal AV&#xD;
&#xD;
          -  Diagnosis of a chronic inflammatory disease such as lupus, multiple sclerosis, cancer,&#xD;
             Chron's disease or cancer&#xD;
&#xD;
          -  Allergies to Astaxanthin (microalgae), Grape Seed Extract, Kiwi fruit or Kiwi extract,&#xD;
             Pineapple fruit or extract (bromelain), Rosehip or Rosehip extract, Gooseberry,&#xD;
             Rosehip, Grapes&#xD;
&#xD;
          -  Secondary AV, such as occupational AV, steroid induced AV, or AV associated with&#xD;
             endocrine disorders&#xD;
&#xD;
          -  Having facial dermatosis that may interfere evaluations by IGA such as sunburn,&#xD;
             eczema, psoriasis, erythematotelangectatic rosacea or seborrheic dermatitis&#xD;
&#xD;
          -  Use of isotretinoin within 2 months&#xD;
&#xD;
          -  Use of adapalene or tretinoin within 2 weeks&#xD;
&#xD;
          -  Use of anti-biotics within 2 weeks&#xD;
&#xD;
          -  Use of oral corticosteroids or androgens within 2 weeks&#xD;
&#xD;
          -  Use of anticonvulsants&#xD;
&#xD;
          -  Any subject who the PI deems unsuitable for any reason&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zhaoping Li</last_name>
    <role>Principal Investigator</role>
    <affiliation>UCLA Professor of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UCLA Center for Human Nutrition, 1000 Veteran Ave.</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>August 26, 2020</study_first_submitted>
  <study_first_submitted_qc>August 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 1, 2020</study_first_posted>
  <last_update_submitted>January 25, 2021</last_update_submitted>
  <last_update_submitted_qc>January 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, Los Angeles</investigator_affiliation>
    <investigator_full_name>Zhaoping Li</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>antioxidants</keyword>
  <keyword>acne</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acne Vulgaris</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

